Advertisement
YOU ARE HERE: LAT HomeCollections

BRIEFLY

Cooper Labs is soliciting Rorer Group proxies.

March 20, 1985

Cooper Laboratories announced that it is soliciting the proxies for Rorer's April 23 annual meeting in support of a resolution requesting Rorer's directors to get rid of the "poison pill" share-purchase rights adopted by Rorer's board Feb 7. In its letter to Rorer stockholders, Palo Alto-based Cooper stated that "Rorer's board, in our view, has unilaterally restricted your freedom, and that of other Rorer shareholders, to decide for yourselves whether to sell your shares in a tender offer." Cooper now owns 1.06 million Rorer shares, about 4.96% of the shares outstanding.

Advertisement
Los Angeles Times Articles
|
|
|